A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT01594229 · COMPLETED
Trial details
- NCT number
- NCT01594229
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-21
- Primary completion
- 2020-07-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.